biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by OysterBuctoucheon Jan 06, 2020 11:43am

137 Views

Post# 30522114

RE:RE:New Year advice for JD

JD,

I was only offering some advice to help you and ultimately this board. Your choice obviously re: how you take the advice. When you get sidetracked on some responses you tend to lose credibility as your maturity level drops and you send responses that are not befitting a representative of Bioasis. Otherwise i will continue to look forward to your responses regarding the science and substantial issues facing Bioasis.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages